Impact of a VA-ECMO in Combination with an Extracorporeal Cytokine Hemadsorption System in Critically Ill Patients with Cardiogenic Shock-Design and Rationale of the ECMOsorb Trial.

Franz HaertelThomas LehmannTabitha HellerMichael FritzenwangerRuediger PfeiferDaniel KretzschmarSylvia OttoJurgen BogovikuJulian WestphalChristiane BrueningThomas GecksMirko KaluzaSven Moebius-WinklerPaul Christian Schulze

Published in: Journal of clinical medicine (2023)

; CytoSorbents Europe GmbH, Berlin, Germany) in reducing SIRS and improving hemodynamics in patients with cardiogenic shock who are receiving VA-ECMO. We hypothesize that a reduction in cytokine levels can lead to faster weaning from inotropic and mechanical circulatory support, and ultimately to improved recovery.

Keyphrases

extracorporeal membrane oxygenation
acute respiratory distress syndrome
mechanical ventilation
respiratory failure
clinical trial
study protocol
phase iii
phase ii
intensive care unit